GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Purchase Of Investment

Annji Pharmaceutical Co (ROCO:7754) Purchase Of Investment : NT$0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Annji Pharmaceutical Co Purchase Of Investment?

Annji Pharmaceutical Co's purchase of investment for the six months ended in Jun. 2024 was NT$0.0 Mil. It means Annji Pharmaceutical Co spent NT$0.0 Mil on purchasing investments. Annji Pharmaceutical Co's purchase of investment for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.0 Mil.

Compared with last quarter (NT$0.0 Mil in Dec. 2023 ), Annji Pharmaceutical Co spent the same money on purchasing investments in Jun. 2024 (NT$0.0 Mil).


Annji Pharmaceutical Co Purchase Of Investment Historical Data

The historical data trend for Annji Pharmaceutical Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annji Pharmaceutical Co Purchase Of Investment Chart

Annji Pharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23
Purchase Of Investment
- - -274.00

Annji Pharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Purchase Of Investment - - - - -

Annji Pharmaceutical Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Annji Pharmaceutical Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Annji Pharmaceutical Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Annji Pharmaceutical Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.

Annji Pharmaceutical Co Headlines

No Headlines